Allison joins existing team of world-renowned advisors supporting Ro’s obesity care offerings
NEW YORK, July 24, 2024 /PRNewswire/ — Ro, the leading direct-to-patient healthcare company, today announced obesity research expert David B. Allison will join an existing team of world-renowned experts supporting the company’s obesity care offerings. As Ro continues to scale its comprehensive obesity care offering, Allison will support Ro’s research and educational initiatives. Collectively, Ro’s team of obesity advisors spans expertise in pharmacological, behavioral, and nutritional therapies, as well as patient advocacy and public policy.
“At an exciting time of rapid advancement in the science and practice of obesity medicine, each of our advisors is at the forefront of their fields, driving critical innovation in obesity care. I look forward to continuing to work with our Advisory Board members to use their combined expertise to build a new paradigm for patient-centric care at Ro,” said Melynda Barnes, MD, Chief Medical Officer at Ro.
David B. Allison, PhD, is an award-winning obesity researcher and biostatistician. He is acting as an independent consultant to Ro and not on behalf of or representing any institution. Allison serves as Dean and Distinguished Professor at the Indiana University School of Public Health-Bloomington. Funded by the NIH for over 25 years, Allison has authored more than 700 scientific publications focused on obesity as a disease, nutrition, aging, and longevity.
He joins an existing group of leaders in obesity care, including:
Ro’s expert advisors support the development of clinical strategy and guidelines, educational content, partner in research, and advocate for greater access to obesity care, including coverage of GLP-1s medications to treat obesity. Learn more about Ro’s Advisory Board here: https://ro.co/advisors/
About Ro
Ro is a direct-to-patient healthcare company with a mission of helping patients achieve their health goals by delivering the easiest, most effective care possible. Ro is the only company to offer nationwide telehealth, labs, and pharmacy services. This is enabled by Ro’s vertically integrated platform that helps patients achieve their goals through a convenient, end-to-end healthcare experience spanning from diagnosis, to delivery of medication, to ongoing care. Since 2017, Ro has helped millions of patients in nearly every single county in the United States, including 98% of primary care deserts. Visit ro.co for more information.
Contact: press@ro.co
SOURCE Ro
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…
Montreal-based Thought Technology Ltd wraps up its 50th year in business providing psychophysiological instrumentation to…
The new research from eye care nonprofit Orbis International, supported by Heidelberg Engineering, shows how…
Business wins, strategic collaborations, and renewed commitment to client partnership highlight a year of transformation…